Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 26Other hematologic neoplasm 22Lymphoid 22Genitourinary 20Gastrointestinal 18Thoracic 9Sarcoma 9Gynecologic 9Dermatologic 9CNS 9Myeloid 7Plasma cell 6Other solid neoplasm 3Head & Neck 3Classical hematology 2Tumor-Agnostic 1Other neoplasm 1Endocrine 1

Conditions

Adrenocortical Carcinoma 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Amplified Fragment Length Polymorphism Analysis × Endocrine × Clear all
NCT01528956 2016-05-18

Studying Genes in Samples From Younger Patients With Adrenocortical Tumor

Children's Oncology Group

Completed
10 enrolled
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡